Please also read the following articles:
Alper MM
Experience with ISO quality control in assisted reproductive technology. Fertil Steril. 2013 Dec;100(6):1503-8. doi.org/10.1016/j.fertnstert.2013.08.055.
Boivin J, Bunting L, Collins JA, Nygren KG.
International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Hum Reprod. 2007 Jun;22(6):1506-12. DOI: 10.1093/humrep/dem046.
!
NEW! Cohlen B, Bijkerk A, Van der Poel S, Ombelet W.
IUI: review and systematic assessment of the evidence that supports global recommendations. Hum Reprod Update. 2018 May;24(3):300-319. doi: 10.1093/humupd/dmx041.
Dancet EA, D'Hooghe TM, Spiessens C, Sermeus W, De Neubourg D, Karel N, Kremer JA, Nelen WL.
Quality indicators for all dimensions of infertility care quality: consensus between professionals and patients. Hum Reprod. 2013 Jun;28(6):1584-97. doi: 10.1093/humrep/det056.
Dancet EA, Nelen WL, Sermeus W, De Leeuw L, Kremer JA, D'Hooghe TM.
The patients' perspective on fertility care: a systematic review. Hum Reprod Update. 2010 Sep-Oct;16(5):467-87. doi: 10.1093/humupd/dmq004.
Dancet EA, Van Empel IW, Rober P, Nelen WL, Kremer JA, D'Hooghe TM.
Patient-centred infertility care: a qualitative study to listen to the patient's voice. Hum Reprod. 2011 Apr;26(4):827-33. doi: 10.1093/humrep/der022.
De Geyter Ch, Calhaz-Jorge C, Kupka MS, Wyns C, Mocanu E, Motrenko T, Scaravelli G, Smeenk J, Vidakovic S, Goossens V,
The European IVF-monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE). ART in Europe, 2014: results generated from European registries by ESHRE. Hum Reprod. 2018 Sep;33(9):1586–1601. doi.org/10.1093/humrep/dey242.
ESHRE Special Interest Group of Embryology and Alpha Scientists in Reproductive Medicine.
The Vienna consensus: report of an expert meeting on the development of art laboratory performance indicators. Hum Reprod Open. 2017 Aug;2017(2):1-17. https://doi.org/10.1093/hropen/hox011 (Recommendations of the expert panel only, p. 9 – 17).
ESHRE Task Force on Ethics and Law.
Gamete and embryo donation. Hum Reprod. 2002 May;17(5):1407-8. DOI: 10.1093/humrep/17.5.1407.
Harper J, Magli MC, Lundin K, Barratt CL, Brison D.
When and how should new technology be introduced into the IVF laboratory? Hum Reprod. 2012 Feb;27(2):303-13. doi: 10.1093/humrep/der414.
Hart R, Norman RJ.
The longer-term health outcomes for children born as a result of IVF treatment: Part I--General health outcomes. Hum Reprod Update. 2013 May-Jun;19(3):232-43. doi.org/10.1093/humupd/dms062.
Hart R, Norman RJ.
The longer-term health outcomes for children born as a result of IVF treatment. Part II--Mental health and development outcomes. Hum Reprod Update. 2013 May-Jun;19(3):244-50. doi: 10.1093/humupd/dmt002.
Kirkegaard K, Ahlström A, Ingerslev HJ, Hardarson T.
Choosing the best embryo by time lapse versus standard morphology. Fertil Steril. 2015 Feb;103(2):323-32. doi: 10.1016/j.fertnstert.2014.11.003. doi.org/10.1016/j.fertnstert.2014.11.003.
Kwan I, Bhattacharya S, Knox F, McNeil A.
Pain relief for women undergoing oocyte retrieval for assisted reproduction. Cochrane Database Syst Rev. 2013 Jan 31(1):CD004829. doi: 10.1002/14651858.CD004829.pub3.
Mulley AG, Trimble C, Elwyn G.
Stop the silent misdiagnosis: patients' preferences matter. BMJ. 2012 Nov 8;345:e6572. doi: 10.1136/bmj.e6572.
Pinborg A.
IVF/ICSI twin pregnancies: risks and prevention. Hum Reprod Update. 2005 Nov-Dec;11(6):575-93. DOI: 10.1093/humupd/dmi027
Pinborg A, Wennerholm UB, Romundstad LB, Loft A, Aittomaki K, Söderström-Anttila V, Nygren KG, Hazekamp J, Bergh C.
Why do singletons conceived after assisted reproduction technology have adverse perinatal outcome? Systematic review and meta-analysis. Hum Reprod Update. 2013 Mar-Apr;19(2):87-104. doi: 10.1093/humupd/dms044.
Schmidt L, Sobotka T, Bentzen JG, Nyboe Andersen A. ESHRE Reproduction and Society Task Force.
Demographic and medical consequences of the postponement of parenthood. Hum Reprod Update. 2012 Jan-Feb;18(1):29-43. doi: 10.1093/humupd/dmr040.
Schüring AN, Fehm T, Behringer K, Goeckenjan M, Wimberger P, Henes M, Henes J, Fey MF, von Wolff M.
Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part I: Indications for fertility preservation. Arch Gynecol Obstet. 2018 Jan;297(1):241-255. doi: 10.1007/s00404-017-4594-3.
Sharma R, Biedenharn KR, Fedor JM, Agarwal A.
Lifestyle factors and reproductive health: taking control of your fertility. Reprod Biol Endocrinol. 2013 Jul 16;11:66. doi: 10.1186/1477-7827-11-66.
Shenfield F, Pennings G, Cohen J, Devroey P, de Wert G, Tarlatzis B; ESHRE Task Force on Ethics and Law. ESHRE Task Force on Ethics and Law 10:
surrogacy. Hum Reprod. 2005 Oct;20(10):2705-7. DOI: 10.1093/humrep/dei147
Simpson JL.
Birth defects and assisted reproductive technologies. Semin Fetal Neonatal Med. 2014 Jun;19(3):177-82. doi: 10.1016/j.siny.2014.01.001.
Siristatidis, C, Sergentanis TN, Kanavidis P, Trivella M, Sotiraki M, Mavromatis I, Psaltopoulou T, Skalkidou A, Petridou ET.
Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer – a systematic review and meta-analysis. Hum Reprod Update. 2013 Mar-Apr;19(2):105-123. doi: 10.1093/humupd/dms051.
Sol Olafsdottir H, Wikland M, Möller A.
Nordic couples' decision-making processes during assisted reproduction treatments. Sex Reprod Healthc. 2013 Jun;4(2):49-55. doi: 10.1016/j.srhc.2013.04.003.
van Empel IW, Aarts JW, Cohlen BJ, Huppelschoten DA, Laven JS, Nelen WL, Kremer JA.
Measuring patient-centredness, the neglected outcome in fertility care: a random multicentre validation study. Hum Reprod. 2010 Oct;25(10):2516-26. doi: 10.1093/humrep/deq219.
von Wolff M, Germeyer A, Liebenthron J, Korell M, Nawroth F.
Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part II: fertility preservation techniques. Arch Gynecol Obstet. 2018 Jan;297(1):257-267. doi: 10.1007/s00404-017-4595-2.